1. Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization
   Kyoung-Ok Hong et al, 2019, Molecules CrossRef
2. Therapeutic applications and biological activities of bacterial bioactive extracts
   Zainab Abdelghani et al, 2021, Archives of Microbiology CrossRef
3. IQ Motif-Containing GTPase-Activating Protein 2 Inhibits Breast Cancer Angiogenesis by Suppressing VEGFR2–AKT Signaling
   Dinesh Kumar et al, 2022, Molecular Cancer Research CrossRef
4. Colorectal Cancer and Alcohol Consumption—Populations to Molecules
   Marco Rossi et al, 2018, Cancers CrossRef
5. Feixian Recipe inhibits pulmonary fibrosis by targeting pulmonary microvascular endothelial cells and VEGF/VEGFR2 signaling pathway
   Lihong Meng et al, 2018, Traditional Medicine and Modern Medicine CrossRef
6. Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor–specific inhibitor
   Appu Rathinavelu et al, 2017, Tumor Biology CrossRef
7. Chemical biology of salinomycin
   Antoine Versini et al, 2018, Tetrahedron CrossRef
8. A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents
   Michał Antoszczak, 2019, European Journal of Medicinal Chemistry CrossRef
9. Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway
   Jin-Huan Jiang et al, 2020, Pathology - Research and Practice CrossRef
10. Total Flavones ofAbelmoschus manihotExhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis
    Gui-Song Zhu et al, 2018, The American Journal of Chinese Medicine CrossRef
11. A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent
    Michał Antoszczak, 2019, European Journal of Medicinal Chemistry CrossRef
12. Evaluation of Variances in VEGF-A-D and VEGFR-1-3 Expression in the Ishikawa Endometrial Cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect
    Piotr Kras et al, 2021, Current Pharmaceutical Biotechnology CrossRef
13. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells
    Elia Bozzato et al, 2022, International Journal of Pharmaceutics CrossRef
14. Improved anticancer activity of betulinic acid on breast cancer through a grafted copolymer-based micelles system
    Xueju Qi et al, 2021, Drug Delivery CrossRef
15. Microbial secondary metabolites: as a therapeutic agents
    Ashok V. Kharde et al, 2024, Microbial Essentialism CrossRef
16. Astaxanthin inhibits homocysteine‑induced endothelial cell dysfunction via the regulation of the reactive oxygen species‑dependent VEGF‑VEGFR2‑FAK signaling pathway
    Xian‑Jun Wang et al, 2019, Molecular Medicine Reports CrossRef
17. Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells
    Merve Erkisa et al, 2022, Current Medicinal Chemistry CrossRef
18. Salinomycin attenuates kidney fibrosis and inflammation in mice with unilateral ureteral obstruction
    Kuan-Hsing Chen et al, 2025, Biochemical and Biophysical Research Communications CrossRef
19. A peptide-salinomycin conjugate with a bystander effect reduces the stemness characteristics of ovarian cancer cells and enhances drug sensitivity
    Chaowei Hao et al, 2024, European Journal of Medicinal Chemistry CrossRef
20. Salinomycin and its derivatives – A new class of multiple-targeted “magic bullets”
    Michał Antoszczak et al, 2019, European Journal of Medicinal Chemistry CrossRef